BioLife Solutions Inc. (BLFS) Financial Statements (2026 and earlier)

Company Profile

Business Address 3303 MONTE VILLA PARKWAY
BOTHELL, WA 98021
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments88,927104,58451,69562,70269,86090,403
Cash and cash equivalent33,03895,38635,40719,44269,86090,403
Short-term investments55,8899,19816,28843,260  
Other undisclosed cash, cash equivalents, and short-term investments      
Restricted cash and investments   31311053
Receivables7,9539,16818,65733,93623,2178,006
Inventory, net of allowances, customer advances and progress billings30,15529,01343,45634,90428,34511,602
Inventory30,15529,01343,45634,90428,34511,602
Other undisclosed current assets9,5265,9966,7656,8794,4274,648
Total current assets:136,561148,761120,604138,452125,859114,712
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization   9427244017
Operating lease, right-of-use asset7,46610,67411,44615,29218,7059,675
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization14,7136,08421,07723,63817,65710,120
Debt securities, available-for-sale, accrued interest, after allowance for credit loss31,2504,6285481,332  
Long-term investments and receivables  9955481,332  
Long-term investments  9955481,332  
Intangible asset, including goodwill, after accumulated amortization212,844221,863245,890256,829376,89089,498
Goodwill208,587212,304224,741224,741224,74158,449
Intangible asset, excluding goodwill, after accumulated amortization4,2579,55921,14932,088152,14931,049
Deposits noncurrent assets  379273281325230
Other noncurrent assets3,050     
Other undisclosed noncurrent assets  6,10312,23412,80114,18110,577
Total noncurrent assets:269,323250,726292,110311,777428,198120,117
TOTAL ASSETS:405,884399,487412,714450,229554,057234,829
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,33210,68913,84918,49516,6284,256
Taxes payable✕✕✕✕✕27112
Accounts payable1,4863,5736,94015,36714,9453,672
Accrued liabilities5,8467,1166,9093,1281,656472
Deferred revenue195103661548814931
Debt4,99710,9437,2091,9721,011622
Deferred compensation liability5,9335,2323,8005,0804,3512,898
Derivative instruments and hedges, liabilities      2,780
Business combination, contingent consideration, liability    2,1385,1272,637
Other liabilities    51294130
Other undisclosed current liabilities4,5225,76716,65916,29812,1561,319
Total current liabilities:22,97932,73442,17844,58240,38115,573
Noncurrent Liabilities
Long-term debt and lease obligation  4,99719,48023,91923,1108,769
Long-term debt, excluding current maturities  4,99718,31123,7936,353 
Finance lease, liability   1,16912629112
Liabilities, other than long-term debt11,01712,84713,39317,54010,4295,241
Deferred income tax liabilities1891241882505,487 
Other liabilities171  1042726
Operating lease, liability10,65712,72313,20514,96216,4668,757
Business combination, contingent consideration, liability    2,3184,9004,515
Total noncurrent liabilities:11,01717,84432,87341,45933,53914,010
Total liabilities:33,99650,57875,05186,04173,92029,583
Equity
Equity, attributable to parent371,888348,909337,663364,188480,137205,246
Common stock484745434233
Additional paid in capital711,404683,939651,305611,739585,397302,598
Accumulated other comprehensive income (loss)13224(345)(679)(282) 
Accumulated deficit(339,696)(335,101)(313,342)(246,915)(105,020)(97,385)
Total equity:371,888348,909337,663364,188480,137205,246
TOTAL LIABILITIES AND EQUITY:405,884399,487412,714450,229554,057234,829

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues96,21482,254143,271161,759119,15648,087
Cost of revenue(34,096)(44,306)(93,693)(102,438)(84,501)(22,221)
Gross profit:62,11837,94849,57859,32134,65525,866
Operating expenses(63,199)(45,077)(120,403)(204,862)(68,595)(31,441)
Other undisclosed operating loss(15,521)     
Operating loss:(16,602)(7,129)(70,825)(145,541)(33,940)(5,575)
Nonoperating income (expense)4,521(4,296)4,5677146,1874,978
Investment income, nonoperating  (4,074) 697 1,377
Other nonoperating income1,8154971,264704289 
Interest and debt expense     284 
Other undisclosed loss from continuing operations before equity method investments, income taxes     (284) 
Loss from continuing operations before income taxes:(12,081)(11,425)(66,258)(144,827)(27,753)(597)
Income tax expense (benefit)(49)38(169)5,02220,1183,264
Income (loss) from continuing operations:(12,130)(11,387)(66,427)(139,805)(7,635)2,667
Income (loss) before gain (loss) on sale of properties:✕✕✕✕✕(7,635)2,667
Income (loss) from discontinued operations 7,535(8,797)    
Other undisclosed net income      
Net income (loss) attributable to parent:(4,595)(20,184)(66,427)(139,805)(7,635)2,667
Other undisclosed net loss available to common stockholders, basic      (217)
Net income (loss) available to common stockholders, basic:(4,595)(20,184)(66,427)(139,805)(7,635)2,450
Other undisclosed net loss available to common stockholders, diluted      (3,404)
Net loss available to common stockholders, diluted:(4,595)(20,184)(66,427)(139,805)(7,635)(954)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(4,595)(20,184)(66,427)(139,805)(7,635)2,667
Other comprehensive income 108369334   
Other undisclosed comprehensive income      
Comprehensive income (loss):(4,487)(19,815)(66,093)(139,805)(7,635)2,667
Other undisclosed comprehensive loss, net of tax, attributable to parent (387) (397)(282) 
Comprehensive income (loss), net of tax, attributable to parent:(4,487)(20,202)(66,093)(140,202)(7,917)2,667

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: